These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 21591780

  • 1. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 3. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL, Luna L, Guo Z, Cox NJ, Pirkle JL, Donis RO, Barr JR.
    Vaccine; 2008 May 12; 26(20):2510-20. PubMed ID: 18440105
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM.
    Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287
    [Abstract] [Full Text] [Related]

  • 7. Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
    Pierce CL, Williams TL, Santana WI, Levine M, Chen LM, Cooper HC, Solano MI, Woolfitt AR, Marasco WA, Fang H, Donis RO, Barr JR.
    Vaccine; 2017 Sep 05; 35(37):5011-5018. PubMed ID: 28774565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Morgenstern K, Xie Y, Palladino G, Barr JR, Settembre EC, Williams TL, Wen Y.
    Vaccine; 2018 Oct 01; 36(41):6144-6151. PubMed ID: 30194004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 01; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 14. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 15. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC, Cox MM, Reisinger K, Hedrick J, Graham I, Patriarca P.
    Vaccine; 2009 Nov 05; 27(47):6589-94. PubMed ID: 19716456
    [Abstract] [Full Text] [Related]

  • 18. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 19. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC, Porre AM, de Rond EJ, Hessels WB, Tijms MA, Kessen H, Slotboom AM, Oerlemans MA, Smit D, van der Linden J, Schoen P, Thus JL.
    Vaccine; 2009 Feb 25; 27(9):1468-77. PubMed ID: 19110022
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
    Patel A, Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP.
    Vaccine; 2009 May 18; 27(23):3083-9. PubMed ID: 19428922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.